Human-Centric Innovation
Unknown → Discovery

Gut mechanisms once considered unreachable are now observable on our villus-mimetic organoid chip.
By enabling stable co-culture with strict anaerobes, we transform complex host–microbe interactions into standardized, reproducible readouts that deliver actionable insights for human health.
Complex → Simple

Complex microfluidic setups have long limited adoption and scale.
Our roll-to-roll manufactured, plug-and-play organoid inserts, supported by validated SOP kits, remove those barriers and make advanced biology accessible, reliable, and ready for every lab.
Human-Relevant Organoids Chip

Our chip produces human-relevant datasets aligned with NAM frameworks and current FDA/EMA direction on animal-free innovation.
Validated through barrier integrity, permeability, and tight-junction recovery metrics, these trusted data packages accelerate preclinical decisions and build confidence to advance therapies into the clinic.

VILLIORGAN™ - Gut Organoid on Chip
icon004.jpg
Human-relevant villi with mucin layer
Supports adhesion of anaerobes like Bifidobacterium.
icon005.jpg
Physiological O₂ gradient
Enables co-culture of intestinal cells and strict anaerobes.
icon006.jpg
Scalable & standardized
Roll-to-roll printed chips ready for high-throughput screening (mountable on 24-well plates)
Within a human-relevant gut model,
the hidden world of probiotics comes to light.
From hidden microbes to measurable insights.
Collaborative Applications & Validated Insights
icon011.png
Microbiome Therapeutics & Live Biotherapeutic Products (LBPs)
Our gut organoid chip supports the development of microbiome therapeutics— including LBPs— by validating bacterial adhesion, survival under physiological gradients, and anti-inflammatory effects.
Complex host–microbe interactions become reproducible datasets that accelerate therapeutic discovery.
icon012.png
Infectious Disease Modeling & Translational Insights
Our human-relevant organoid chip enables precise infectious disease modeling by capturing infection dynamics, barrier permeability shifts, and cytokine responses.
These validated datasets provide actionable insights for translational research, supporting new anti-infective therapies and vaccine development.